621
Views
3
CrossRef citations to date
0
Altmetric
Review

Recent advances in the discovery and development of TLR ligands as novel therapeutics for chronic HBV and HIV infections

, , , , , & show all
Pages 661-670 | Received 30 Nov 2017, Accepted 02 May 2018, Published online: 17 May 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Sandra Phillips, Ravi Jagatia & Shilpa Chokshi. (2022) Novel therapeutic strategies for chronic hepatitis B. Virulence 13:1, pages 1111-1132.
Read now
Xuan Huang, Xiaoyong Zhang & Mengji Lu. (2021) Recent trends in the development of Toll-like receptor 7/8-targeting therapeutics. Expert Opinion on Drug Discovery 16:8, pages 869-880.
Read now
Allan Ma, Bruce Motyka, Klaus Gutfreund, Yuenian Eric Shi & Rajan George. (2020) A dendritic cell receptor-targeted chimeric immunotherapeutic protein (C-HBV) for the treatment of chronic hepatitis B. Human Vaccines & Immunotherapeutics 16:4, pages 756-778.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.